Xiangya Hospital Central South University

Site:	Xiangya Hospital Central South University
Address:
City:	Changsha
State:	Hunan
Zip:	410013
Country:	China

Phase	Trial	Trial Status	Site Status	Drug	NCT#
	Apatinib Mesylate (Rivoceranib) Versus Standard Second-line TKI in the Treatment of Advanced GIST	Recruiting	Active	Apatinib Mesylate	NCT05751733